Dual-Action GLP-1/GIP
Mounjaro (Tirzepatide)
Dual-action GLP-1/GIP therapy. Shown in clinical studies to support weight loss when prescribed appropriately. Acts on appetite regulation and metabolic pathways. Up to 22% body weight reduction in trials.
Learn About Mounjaro
